Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-HBs Antibody Persistence 5-6 Years After Engerix-B Vaccination
NCT00329576Phase 4Completed
- Sponsor
- GSK
- Start
- May 2006
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 3
01
Overview
A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started May 2006; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00329576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329576.